November 20, 2017 Columns by Ed Tobias MS News That Caught My Eye Last Week: Cannabis Studies, Oral Therapy Study, and Exercising with Wii MMJ Hires Lead Investigator for Phase 2 Trials of Medicinal Cannabis to Treat Progressive MS The real news here is what hiring a lead investigator means. It means that Phase 2 trials of a medical marijuana…
November 17, 2017 Columns by Ed Tobias Airport Tips for Holiday Flyers Thanksgiving is just a few days away, so I thought it would be a good time to repeat a few of my airline travel tips and add a few new ones. Get the wait-time app Needless to say,…
November 14, 2017 Columns by Ed Tobias Thanks to Caregivers Who Share Our MS Load The MS load we carry is heavy. Some of us, unfortunately, must carry it alone. But many of us are fortunate to have someone with whom we can share the weight. It’s National Family Caregivers Month…
November 13, 2017 Columns by Ed Tobias MS News That Caught My Eye Last Week: Myelin Repair, MS Blood Test, Comparing DMTs Myelin-producing Brain Cells Regenerated Using Stem Cells in Early Study We know that when the myelin coating of our nerve axons is destroyed, MS symptoms result. So a process that halts or reverses that destruction is…
November 7, 2017 Columns by Ed Tobias Thinking About Stopping Your MS Treatments? Have you ever thought about stopping whatever MS treatment you’re using? I have. So has John Corboy. Corboy’s not an MS patient. Rather, he’s a researcher at the University of Colorado’s medical school. And he’s studying…
November 6, 2017 Columns by Ed Tobias MS News That Caught My Eye Last Week: Older Patients, Stem Cells, Myelin, B-cells vs. T-cells #MSParis2017 – Trial to See if Disease-modifying Therapies Not Necessary in Older MS Patients This tops my list this week because, at age 69, I certainly fit the definition of an “older” MS patient. The study…
November 3, 2017 Columns by Ed Tobias Dealing with Disaster While Dealing with MS Are you ready for a disaster? Wildfires in the wine country of Northern California exploded so quickly that survivors say they didn’t know they were threatened until flames were nearly at their doors. Hurricane Harvey forced…
October 31, 2017 Columns by Ed Tobias MS Relapses May Be Significantly Under-Reported. Duh. This comes as no surprise to me and probably not to you. MS patients may not always contact their healthcare providers when they’re having a relapse. This information comes via a pair of surveys that were released…
October 30, 2017 Columns by Ed Tobias MS News That Caught My Eye Last Week: #MSParis, Biotin, Tysabri, Lemtrada, Propionic Acid Reports There’s been a lot of interest in the treatments (including natural treatments) for progressive MS that were presented at the ECTRIMS-ACTRIMS conference in Paris last week. Here are a few of our reports involving that research.
October 27, 2017 Columns by Ed Tobias Patients and Neurologists Team Up to Gather MS Therapy Data Since the approval of the first disease-modifying drug (DMD) for MS back in the mid-1990s, another dozen or so have been added as treatment options. But, just as MS affects each patient differently, so do the drugs.
October 24, 2017 Columns by Ed Tobias When You Read About MS Treatments, Read Past the Headline There’s been some internet buzz recently about the possibility of an over-the-counter allergy drug that helps to repair the myelin that MS damages. The drug is clemastine fumarate, and I suspect that some of that…
October 23, 2017 Columns by Ed Tobias MS News That Caught My Eye Last Week: Mavenclad, Tecfidera, Ublituximab, Ocrevus The giant ECTRIMS/ACTRIMS MS conference begins in Paris on Wednesday, Oct. 25, and this column focuses on several of the presentations on which Multiple Sclerosis News Today will be reporting during the week. #MSParis2017 – Mavenclad…
October 20, 2017 Columns by Ed Tobias Opening People’s Eyes to Our Invisible MS Those of us who have MS know that our disease can be invisible. We don’t always stumble when we walk. We don’t always use some sort of an assistive device that would alert people to our illness. So what…
October 17, 2017 Columns by Ed Tobias MSParis2017 Will Look at New MS Diagnosis Criteria, and a Lot More The year’s largest gathering of multiple sclerosis “minds” starts on Oct. 25 in Paris. More than 8,000 neurologists, researchers and others who specialize in treating and curing MS will be attending MSParis2017. It’s a joint meeting…
October 16, 2017 Columns by Ed Tobias MS News That Caught My Eye Last Week: Myelin repair, and Diets High in Fat or Salt Common Allergy Treatment Restores Protective Neuron Coating in MS, Trial Suggests This is the kind of news we all hope to hear. A treatment that will repair our frayed “wires” and, in doing so, restore some…
October 13, 2017 Columns by Ed Tobias Specialty Pharmaceuticals Mean Specialty Prices If you have MS, you’ve probably used a specialty drug. My first was Avonex, which I began to use about 1998. Several others followed. There’s no formal definition of a specialty drug, but these therapies have several things…
October 9, 2017 Columns by Ed Tobias MS News that Caught My Eye Last Week: Lemtrada, Copaxone Generic, ATL1102 Trial, and Brain Stimulation Lemtrada Prevented Progression of Multiple Sclerosis for Five Years, Study Shows Full disclosure: I’m being treated with Lemtrada, so any news about it lights up my radar like a Christmas tree. I’m 10 months post-round 1…
October 6, 2017 Columns by Ed Tobias Therapy That Just Might Beat MS Fatigue I’ve had a cold for two weeks. So, I’ve been more tired than usual. Too tired, in fact, to write the column that was supposed to post last Tuesday. (I apologize to all of you who wait,…
October 2, 2017 Columns by Ed Tobias MS News That Caught My Eye Last Week: Scooter-User Falls, Aggressive Treatment, and Brain Inflammation Falls Common Among Wheelchair, Scooter Users in People with MS, Study Reports It’s happened to me. I’ve gone over backward when I tried to “gun” the throttle of my lightweight scooter when its rear wheels were up…
September 29, 2017 Columns by Ed Tobias She Has MS and She’s Planning to Hike 500 Miles April Hester has MS. She was diagnosed in 1996, just after she turned 20 years old. Like many of us, April has balance and fatigue issues. Her legs can become tired, her foot sometimes drops and she…
November 30, 2023 Columns by Benjamin Hofmeister Is multiple sclerosis everywhere, or am I just more aware of it now?